Company page

Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. is a public company traded under the ticker INDV on the American market. With a market capitalization of approximately $4.67 billion, Indivior focuses on developing and commercializing innovative treatments for addiction and related disorders. The company is committed to improving patient outcomes through its specialized pharmaceutical products.